Inanc, N. Et Al. 2017. Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?. ARTHRITIS & RHEUMATOLOGY , vol.69 .

Inanc, N., Ozen, G., Yalcinkaya, Y., Dalkilic, E., KOCA, S. S., CAN, G., ... KARATAŞ, A.(2017). Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?. ARTHRITIS & RHEUMATOLOGY , vol.69.

Inanc, Nevsun Et Al. "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?," ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Inanc, Nevsun Et Al. "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?." ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Inanc, N. Et Al. (2017) . "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?." ARTHRITIS & RHEUMATOLOGY , vol.69.

@article{article, author={Nevsun Inanc Et Al. }, title={Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2017}